Hippocampus and Insula Are Targets in Epileptic Patients With Glutamic Acid Decarboxylase Antibodies

Background: Antibodies to glutamic acid decarboxylase (GAD ab) have been found in patients with limbic encephalitis (LE) and chronic pharmacoresistant focal epilepsy (FE). The objectives of the study were to: (1) analyze the clinical and neuroimaging course of patients with FE+GAD ab, (2) compare th...

Descripción completa

Detalles Bibliográficos
Autores principales: Falip, Mercè, Rodriguez-Bel, Laura, Castañer, Sara, Sala-Padró, Jacint, Miro, Júlia, Jaraba, Sónia, Casasnovas, Carlos, Morandeira, Francisco, Berdejo, Javier, Carreño, Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334555/
https://www.ncbi.nlm.nih.gov/pubmed/30687213
http://dx.doi.org/10.3389/fneur.2018.01143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334555/
https://www.ncbi.nlm.nih.gov/pubmed/30687213
http://dx.doi.org/10.3389/fneur.2018.01143

Ejemplares similares